Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Dovitinib (50 and 75 mg/kg) results in 97% and 98% tumor growth inhibition
R112 also blocked leukotriene C4 production and all proinflammatory cytokines tested
43 μM) and causes altered cell cycle progression most clearly revealed under conditions of recovery from serum starvation
+1/p-1/b18-17+
It inhibits the demethylase activity of Jumonji enzymes in vitro
GSK-2981278 - CAS# 1474110-21-8 Catalog No.:M6485-10 Dovitinib (50 and 75 mg/kg)GSK 2981278, CAS No. 1474110 21 8, is a highly potent and selective inverse agonist of retinoic acid receptor related orphan receptor gamma (ROR gamma). GSK 2981278 is a strong ROR selective inverse agonist that inhibits activation of the il17 promoter. GSK 2981278 robustly inhibits ROR mediated cytokine production at both the mRNA and protein level. GSK 2981278 attenuates inflammation in a mouse model of psoriasis. Topical treatment with GSK 2981278
US$ 15.00
US$ 25.95
US$ 18.00
US$ 19.00
US$ 20.00
US$ 47.99